RT @Reza_Zadeh: Model generates a novel drug in 21 days, & after 25 more days of synthesis & testing, its predicted biological & chemical p…
RT @Reza_Zadeh: Model generates a novel drug in 21 days, & after 25 more days of synthesis & testing, its predicted biological & chemical p…
RT @Reza_Zadeh: Model generates a novel drug in 21 days, & after 25 more days of synthesis & testing, its predicted biological & chemical p…
RT @Reza_Zadeh: Model generates a novel drug in 21 days, & after 25 more days of synthesis & testing, its predicted biological & chemical p…
RT @Reza_Zadeh: Model generates a novel drug in 21 days, & after 25 more days of synthesis & testing, its predicted biological & chemical p…
RT @Reza_Zadeh: Model generates a novel drug in 21 days, & after 25 more days of synthesis & testing, its predicted biological & chemical p…
RT @Reza_Zadeh: Model generates a novel drug in 21 days, & after 25 more days of synthesis & testing, its predicted biological & chemical p…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @Reza_Zadeh: Model generates a novel drug in 21 days, & after 25 more days of synthesis & testing, its predicted biological & chemical p…
RT @Reza_Zadeh: Model generates a novel drug in 21 days, & after 25 more days of synthesis & testing, its predicted biological & chemical p…
RT @Reza_Zadeh: Model generates a novel drug in 21 days, & after 25 more days of synthesis & testing, its predicted biological & chemical p…
RT @cnancyxu: There are a lot of minds in #AI for #DrugDiscovery nowadays, and it finally looks like we’re making progress. Designed, valid…
RT @Reza_Zadeh: Model generates a novel drug in 21 days, & after 25 more days of synthesis & testing, its predicted biological & chemical p…
Identification of DDR1 kinase inhibitors by RL + variational inference in @NatureBiotech: https://t.co/wZ1thsDDZt, @biogerontology https://t.co/Wvt0lzPpke
RT @Reza_Zadeh: Model generates a novel drug in 21 days, & after 25 more days of synthesis & testing, its predicted biological & chemical p…
RT @Reza_Zadeh: Model generates a novel drug in 21 days, & after 25 more days of synthesis & testing, its predicted biological & chemical p…
RT @Reza_Zadeh: Model generates a novel drug in 21 days, & after 25 more days of synthesis & testing, its predicted biological & chemical p…
@moh_fcis I assume this is your domain ?
RT @Reza_Zadeh: Model generates a novel drug in 21 days, & after 25 more days of synthesis & testing, its predicted biological & chemical p…
Model generates a novel drug in 21 days, & after 25 more days of synthesis & testing, its predicted biological & chemical properties were confirmed as favorable in mice. Paper: https://t.co/GlAMBVMabs Code: https://t.co/LGLj6xO5fd https://t.co
Congrats to friends at Insilico Medicine Ola Popova Alex Zhavoronkov for publishing in Nature Biotech how AI can speed up drug discovery 🙌 I'm so excited to continue to follow this company's progress ! https://t.co/QVNfg1LjYL
Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/ZeIycPwAI8 https://t.co/HCv4AANhpN
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @InSilicoMeds: Biggest News Today. Insilico Medicine's team made a breakthrough in AI for drug discovery last year. Today we are far ah…
Deep learning enables rapid identification of potent DDR1 kinase inhibitors #insilico #insilicomedicine #ai #DDR1, #Nature #insilicomeds, published in #NatureBiotech, #InsilicoAI @biogerontology https://t.co/E4cN3G82Eo
Drug discovery: Deep learning enables rapid identification of potent DDR1 kinase inhibitors: https://t.co/48uTGWpAnd #BChealth #cdnecon #drugs
RT @MrJeffKarp: Deep learning enables rapid identification of potent DDR1 kinase inhibitors - a kinase target implicated in fibrosis and ot…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @EngIPM: "In my view, the fact that they were able to generate entirely novel, pharmacologically viable compounds using AI is the most a…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @EngIPM: "In my view, the fact that they were able to generate entirely novel, pharmacologically viable compounds using AI is the most a…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @ElementoLab: First ever demonstration that AI can generate entirely novel, synthesizable, active molecules against specific pharmacolog…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @ElementoLab: First ever demonstration that AI can generate entirely novel, synthesizable, active molecules against specific pharmacolog…
RT @BuckInstitute: Congrats to Buck adjunct professor Dr. Alex Zhavoronkov (@biogerontology) on his group's new paper in @NatureBiotech htt…
"In my view, the fact that they were able to generate entirely novel, pharmacologically viable compounds using AI is the most amazing achievement here," said @EngIPM Director Olivier Elemento, Ph.D. (@ElementoLab) @WeillCornell #AI #PrecisionMedicine ht
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @InSilicoMeds: Biggest News Today. Insilico Medicine's team made a breakthrough in AI for drug discovery last year. Today we are far ah…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @InSilicoMeds: Biggest News Today. Insilico Medicine's team made a breakthrough in AI for drug discovery last year. Today we are far ah…
RT @BuckInstitute: Congrats to Buck adjunct professor Dr. Alex Zhavoronkov (@biogerontology) on his group's new paper in @NatureBiotech htt…
RT @BuckInstitute: Congrats to Buck adjunct professor Dr. Alex Zhavoronkov (@biogerontology) on his group's new paper in @NatureBiotech htt…
Congrats to Buck adjunct professor Dr. Alex Zhavoronkov (@biogerontology) on his group's new paper in @NatureBiotech
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @biogerontology: I admire your work, @ElementoLab , this comment is means a lot to our lab! https://t.co/vJ5iBr7seb
I admire your work, @ElementoLab , this comment is means a lot to our lab!
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @biogerontology: From the author of @Deep__Medicine. A book all of us own and we were mentioned in the book. With GANs! The team is supe…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
@AISciNet faster drug discovery https://t.co/phXxtjCwdC #deeplearning #MachineLearning @RSC_CICAG
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @ahmetilker1: Pharma’s #AlphaGo Moment: For First Time AI Has Designed and Validated a New #Drug in Days. Insilico #Medicine has using #…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
Pharma’s #AlphaGo Moment: For First Time AI Has Designed and Validated a New #Drug in Days. Insilico #Medicine has using #AI to design a new molecule from scratch and validate it in just 46 days, compared to 2-3 years currently required. #DigitalHealth htt
@biogerontology (@TrendsinPharma author) and colleagues publish @NatureBiotech
RT @DeepTech2_0: Congratulations to @InSilicoMeds. It's Pharma’s AlphaGo Moment: For the First Time, Artificial Intelligence Has Designed a…
RT @HartungIngo: A new case study about deep learning in drug discovery @NatureBiotech: in 7 weeks to potent, cell active & lead-like DDR1…
RT @CellBio_Dude: Interesting article using computer learning to make novel drugs at a breakneck pace. #AI #Drugdiscovery #biotech #pharma…
Interesting article using computer learning to make novel drugs at a breakneck pace. #AI #Drugdiscovery #biotech #pharma #pharmaceuticals
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @InSilicoMeds: Biggest News Today. Insilico Medicine's team made a breakthrough in AI for drug discovery last year. Today we are far ah…
Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/qfYp5Gqei7 https://t.co/s8I3Bjc4fS
Amazing! A #MachineLearning approach 2 de novo drug design based on: 1) synthetic feasibility; 2) effectiveness against a target; 3) distinctiveness relative 2 other molecules in the public domain. 46 days from target to validated hits. @NatureBiotech ht
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
Congratulations to @InSilicoMeds. It's Pharma’s AlphaGo Moment: For the First Time, Artificial Intelligence Has Designed a New Drug in 21 Days #tech #biotech #ai #Biotechnology
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
The remarkable accomplishment of our flagship portfolio company @InSilicoMeds acknowledged also by @EricTopol #AI #DrugDiscovery #Biotech #tech #pharmacy
RT @HartungIngo: A new case study about deep learning in drug discovery @NatureBiotech: in 7 weeks to potent, cell active & lead-like DDR1…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
👇
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @ARK_KCL: Congratulations to our collaborator Alex Zhavoronkov @biogerontology CEO @InSilicoMeds for his ground breaking @NatureB…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
Pharma’s AlphaGo Moment: For First Time AI Has Designed and Validated a New Drug in Days https://t.co/bnm0k0Nntc Deep learning enables rapid identification of potent DDR1 kinase inhibitors. https://t.co/fIKRAPpfvE #AI #drugdevelopment #pharmaceuticals #d
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
https://t.co/GBFuor1mwT Deep learning enables rapid identification of potent DDR1 kinase inhibitors by Alex Zhavoronkov Yan Ivanenkov et al. Tao Guo Alán Aspuru-Guzik Generative Tensorial Reinforcement Learning GENTRL 6 inhibitors 3 active (bioch) 2 va
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…